Mark Perreault is Senior Director of Research & Development at Repligen Corp., a bioprocessing-focused life sciences company bringing expertise and innovation to customers since 1981. Mark earned his ...

A novel continuous monoclonal antibody (mAb) production process could help drug firms reach quality goals and cope with changing capacity needs, according to CDMO Fujifilm Diosynth Biotechnologies.

Discover the latest insights in monoclonal antibody production with this exclusive eBook: "Monoclonal Antibody Manufacturing Trends." Published by Cell Culture Dish, this eBook delves into the current ...

ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies The project, with a total value of up ...